Aimmune Therapeutics, Inc. — key financial figures for fiscal year 2019 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2019)

-$248.5M

Total Assets (FY2019)

$204.4M

Total Equity (FY2019)

$104.0M

Cash Flows from Operating Activities (FY2019)

-$195.4M

Source: Aimmune Therapeutics, Inc. 10-K filing (FY2019). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.